WHOLESALE prices continued to slowdown in January, reflecting easing price increases across several commodity groups, the ...

The addition of hormone therapy to radiotherapy improves overall survival in men with high-risk prostate cancer, over ...

The introduction of the Premium Annotation Service at CRS outlets, according to Catubuan, reflects the continuing commitment of the PSA to bring efficient, responsive, and high-quality civil ...

The Philippine Statistics Authority (PSA) Ilocos Norte Provincial Statistical Office and the Ilocos Norte Civil Registrars Association (INCRA) concluded the 36th Civil Registration Month (CRM) on ...

A leading professor who specialises in the research of prostate cancer has revealed the one thing all men should know and ask ...

BioNTech and partner DualityBio are accelerating the development of their B7-H3 antibody-drug conjugate into a phase 3 trial for metastatic castration-resistant prostate cancer (mCRPC). | BioNTech and ...

Data from Vista Health, a leading UK provider of private diagnostic services, has revealed the worrying knowledge gap when it comes to the prostate, as 26 percent of men do not know what their ...

The Government has issued an important statement on prostate cancer and the potential for a screening programme, starting ...

An experimental immunotherapy drug called VIR-5500 has driven prostate-specific antigen (PSA) levels down by as much as 99% in some men with metastatic castration-resistant prostate cancer, according ...

Senators on Monday called out the Philippine Statistics Authority for its slow response to fraudulent registration records of foreign nationals in the country.

STMicroelectronics’ new STM32 series redefines entry-level microcontroller performance and value for smart devices everywhereSTM32C5 with ...

PEACE-2 finds adding cabazitaxel to ADT plus radiotherapy fails to improve survival in high-risk localized prostate cancer, while increasing severe toxicities and deaths.